Primary Care Diabetes
Volume 2, Issue 1 , Pages 59-61, 2008

The future of inhaled insulin and incretinmimetics in the management of diabetes

  • Anthony H. Barnett

      Affiliations

    • Department of Diabetes/Endocrinology, University of Birmingham, United Kingdom
    • Department of Medicine, Undergraduate Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, United Kingdom
    • Corresponding Author InformationCorrespondence address: Department of Medicine, Undergraduate Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, United Kingdom. Tel.: +44 121 424 3587; fax: +44 121 424 0593.

Received 2 January 2008; accepted 8 January 2008. published online 21 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1751-9918(08)00002-8

doi:10.1016/j.pcd.2008.01.001

Primary Care Diabetes
Volume 2, Issue 1 , Pages 59-61, 2008

Article Tools